LYMPHATIC SYSTEM-TARGETING COMPOUNDS

The disclosure provides lymphatic system-targeting compounds of Formula (I), and pharmceutically acceptable salts thereof, pharmaceutical compositions thereof and and methods of treating various conditions associated with NMDA receptor modulation. L'invention concerne des composés ciblant le sy...

Full description

Saved in:
Bibliographic Details
Main Authors QUIRK, Michael C, MARTINS, Andrew Anthony, HILL, Matthew D, LEGASSIE, Jason
Format Patent
LanguageEnglish
French
Published 07.11.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
STEROIDS
Online AccessGet full text

Cover

More Information
Summary:The disclosure provides lymphatic system-targeting compounds of Formula (I), and pharmceutically acceptable salts thereof, pharmaceutical compositions thereof and and methods of treating various conditions associated with NMDA receptor modulation. L'invention concerne des composés ciblant le système lymphatique de formule (I), et des sels pharmaceutiquement acceptables de ceux-ci, des compositions pharmaceutiques de ceux-ci et des procédés de traitement de diverses conditions associées à la modulation du récepteur NMDA.
Bibliography:Application Number: WO2024US27554